Pahwa R, Lyons KE (aprilie 2009). „Levodopa-related wearing-off in Parkinson's disease: identification and management”. Current Medical Research and Opinion. 25 (4): 841–9. doi:10.1185/03007990902779319. PMID19228103.
Forsberg M, Lehtonen M, Heikkinen M, Savolainen J, Järvinen T, Männistö PT (februarie 2003). „Pharmacokinetics and pharmacodynamics of entacapone and tolcapone after acute and repeated administration: a comparative study in the rat”. The Journal of Pharmacology and Experimental Therapeutics. 304 (2): 498–506. doi:10.1124/jpet.102.042846. PMID12538800.
drugbank.ca
„Entacapone”. DrugBank - Canadian Institutes of Health Research. Accesat în .
Pahwa R, Lyons KE (aprilie 2009). „Levodopa-related wearing-off in Parkinson's disease: identification and management”. Current Medical Research and Opinion. 25 (4): 841–9. doi:10.1185/03007990902779319. PMID19228103.
Forsberg M, Lehtonen M, Heikkinen M, Savolainen J, Järvinen T, Männistö PT (februarie 2003). „Pharmacokinetics and pharmacodynamics of entacapone and tolcapone after acute and repeated administration: a comparative study in the rat”. The Journal of Pharmacology and Experimental Therapeutics. 304 (2): 498–506. doi:10.1124/jpet.102.042846. PMID12538800.